Enrollment data

Management will be even more aware when the stockholders understand what is going on. While in the long, you are right about the stock price, there is a lot of irrational exuberance with respect to stocks that are seen as solutions to Covid. That exuberance can lead to unusually high stock prices that enable raising the funds needed to finance the trials for the many indications that are being left behind. For CYDY, Covid is THE opportunity to make everything else happen.

NP is the head of CYDY, for better or for worse. At this point, his priorities are the company's priorities. I agree with the Covid priority because the short term gain, if realized will fund its total mission. Covid, hopefully, will go away. However, the dividends of leronlimab as the cure will favorably reverberate over the long term.